West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
260.85
-5.08 (-1.91%)
Apr 9, 2026, 2:40 PM EDT - Market open
WST Employees
West Pharmaceutical Services had 10,800 employees as of December 31, 2025. The number of employees increased by 200 or 1.89% compared to the previous year.
Employees
10,800
Change (1Y)
200
Growth (1Y)
1.89%
Revenue / Employee
$284,639
Profits / Employee
$45,713
Market Cap
18.79B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10,800 | 200 | 1.89% |
| Dec 31, 2024 | 10,600 | 0 | - |
| Dec 31, 2023 | 10,600 | -100 | -0.93% |
| Dec 31, 2022 | 10,700 | 635 | 6.31% |
| Dec 31, 2021 | 10,065 | 865 | 9.40% |
| Dec 31, 2020 | 9,200 | 1,000 | 12.20% |
| Dec 31, 2019 | 8,200 | 500 | 6.49% |
| Dec 31, 2018 | 7,700 | 200 | 2.67% |
| Dec 31, 2017 | 7,500 | 200 | 2.74% |
| Dec 31, 2016 | 7,300 | 200 | 2.82% |
| Dec 31, 2015 | 7,100 | 100 | 1.43% |
| Dec 31, 2014 | 7,000 | 100 | 1.45% |
| Dec 31, 2013 | 6,900 | 200 | 2.99% |
| Dec 31, 2012 | 6,700 | 400 | 6.35% |
| Dec 31, 2011 | 6,300 | -300 | -4.55% |
| Dec 31, 2010 | 6,600 | 192 | 3.00% |
| Dec 31, 2009 | 6,408 | 108 | 1.71% |
| Dec 31, 2008 | 6,300 | -178 | -2.75% |
| Dec 31, 2007 | 6,478 | 155 | 2.45% |
| Dec 31, 2006 | 6,323 | 753 | 13.52% |
| Dec 31, 2005 | 5,570 | 1,220 | 28.05% |
| Dec 31, 2004 | 4,350 | -15 | -0.34% |
| Dec 31, 2003 | 4,365 | 225 | 5.43% |
| Dec 31, 2002 | 4,140 | 180 | 4.55% |
| Dec 31, 2001 | 3,960 | -740 | -15.74% |
| Dec 31, 2000 | 4,700 | -100 | -2.08% |
| Dec 31, 1999 | 4,800 | 0 | - |
| Dec 31, 1998 | 4,800 | 0 | - |
| Dec 31, 1997 | 4,800 | -240 | -4.76% |
| Dec 31, 1996 | 5,040 | -170 | -3.26% |
| Dec 31, 1995 | 5,210 | 1,530 | 41.58% |
| Dec 31, 1994 | 3,680 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Becton, Dickinson and Company | 72,000 |
| Medline | 45,000 |
| Baxter International | 37,500 |
| Alcon | 25,942 |
| Solventum | 20,584 |
| Align Technology | 20,290 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
WST News
- 8 hours ago - West to Host First-Quarter 2026 Conference Call - PRNewsWire
- 9 days ago - West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity - PRNewsWire
- 4 weeks ago - West Pharma CEO Eric Green to retire after 11 years at the helm - Reuters
- 4 weeks ago - Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc. - PRNewsWire
- 5 weeks ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - West Announces Quarterly Dividend and Share Repurchase Program - PRNewsWire
- 2 months ago - West Pharma forecasts 2026 profit above estimates on strong demand for drug components - Reuters
- 2 months ago - West Reports Fourth-Quarter and Full-Year 2025 Results - PRNewsWire